CZ ATC V08AB07 · updated 2 Nov 2026
Ioversol shortage in Czechia
Is there an Ioversol shortage in Czechia?
Yes. As of 2 Nov 2026, 3 Ioversol products are reported short in Czechia, the first since 1 Jan 2025. The company estimate for the return is 6 Nov 2026 (latest 30 Apr 2027). Main reason: manufacturing problem.
Also short in Canada, Italy, Spain, Belgium. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | OPTIRAY 300MG I/ML 300MG I/ML INJ/INF SOL 25X50ML A | Guerbet, Roissy CdG Cedex | 1 Jan 2025 | 31 Jan 2027 | Manufacturing problem Výrobní důvody |
| CZ | OPTIRAY 350MG I/ML 350MG I/ML INJ/INF SOL 10X500ML A | Guerbet, Roissy CdG Cedex | 23 Sep 2026 | 6 Nov 2026 | Distribution or logistics Kapacitní/distribuční důvody |
| CZ | OPTIRAY 350MG I/ML 350MG I/ML INJ/INF SOL 25X50ML A | Guerbet, Roissy CdG Cedex | 30 Sep 2026 | 30 Apr 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.